Vivek Reddy, MD Email Vivek Reddy
-
- Position
- PROFESSOR | Medicine, Cardiology
-
- Language
- English
-
- Hospital Affiliation
- The Mount Sinai Hospital
- Director, Cardiac Arrhythmia Service
- The Leona M. and Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology
Click here to see Dr. Reddy's video on Atrial Fibrillation.
Vivek Y. Reddy, MD is Director of Cardiac Arrhythmia Services for The Mount Sinai Hospital and the Mount Sinai Health System, and The Leona M. and Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology at Icahn School of Medicine at Mount Sinai.
Dr. Reddy is one of the nation’s premier cardiac electrophysiologists, leading a team of physician-scientists who are developing and testing advanced therapies for cardiac arrhythmias – including atrial fibrillation and ventricular tachycardias, the most common cause of sudden cardiac death. His team offers the full spectrum of arrhythmia therapies.
Dr. Reddy’s pioneering clinical research is changing the way cardiac patients are treated and cured. Under his leadership, Mount Sinai is the lead investigator on several multinational clinical trials exploring new arrhythmia procedures and technologies.
In addition, in 2014 Dr. Reddy implanted inside a patient's heart the world’s first miniature leadless pacemaker in the United States at The Mount Sinai Hospital.
Clinical Focus
- Atrial Fibrillation
- Atrial Flutter
- Cardiomyopathy
- Cardioversion
- Electrophysiology Study
- Renovascular Hypertension
- Stroke
- Tachycardia
- Ventricular Fibrillation
- Ventricular Tachycardia
Language
English
2009
Endowed Professorship: The Leona M. and Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology
2009
The Leona M. and Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology
2007
Best Doctors in Boston
2000
CIMIT Fellowship
Center for Minimally Invasive Therapy
1992
Howard Hughes Medical Institute Scholarship
1989
Alpha Omega Alpha Medical Society
Catheter Ablation of Atrial Fibrillation (AF)
AF is the most common heart arrhythmia. Medications are only modestly effective, so we are working on catheter-based approaches to treat AF by directly cauterizing the tissue causing the problem. We are working with other approaches to do this catheter ablation procedure using laser energy or cryo energy (freezing tissue).
Left Atrial Appendage Closure
People with AF are at high risk for stroke-thus most people receive Warfarin Rx. We are working on approaches to use catheters to close the left atrial appendage. Then, patients would be protected from stroke without having to take Warfarin (Coumadin).
Catheter Ablation of Ventricular Tachycardia (VT)
Ventricular tachycardias are the most common cause of sudden death. The standard approach is to place defibrillators (ICDs) in patients at high risk for sudden death. We are working on approaches to use catheters to cauterize (ablate) the tissue responsible for these arrhythmias.
Reddy VY, Neuzil P, Taborsky M, Ruskin JN. Short-term results of substrate mapping and radiofrequency ablation of ischemic ventricular tachycardia using a saline-irrigated catheter. J Am Coll Cardiol 2003 Jun; 41(12): 2228-2236.
D'Avila A, Scanavacca M, Sosa E, Ruskin JN, Reddy VY. Pericardial anatomy for the interventional electrophysiologist. J Cardiovasc Electrophysiol 2003 Apr; 14(4): 422-430.
Reddy VY, Malchano ZJ, Holmvang G, Schmidt EJ, d'Avila A, Houghtaling C, Chan RC, Ruskin JN. Integration of cardiac magnetic resonance imaging with three-dimensional electroanatomic mapping to guide left ventricular catheter manipulation: feasibility in a porcine model of healed myocardial infarction. J Am Coll Cardiol 2004 Dec 7; 44(11): 2202-2213.
Mikaelian BJ, Malchano ZJ, Neuzil P, Weichet J, Doshi SK, Ruskin JN, Reddy VY. Images in cardiovascular medicine. Integration of 3-dimensional cardiac computed tomography images with real-time electroanatomic mapping to guide catheter ablation of atrial fibrillation. Circulation 2005 Jul; 112(2): e35-36.
Obel OA, d'Avila A, Neuzil P, Saad EB, Ruskin JN, Reddy VY. Ablation of left ventricular epicardial outflow tract tachycardia from the distal great cardiac vein. J Am Coll Cardiol 2006 Nov 7; 48(9): 1813-1817.
Aryana A, d'Avila A, Heist EK, Mela T, Singh JP, Ruskin JN, Reddy VY. Remote magnetic navigation to guide endocardial and epicardial catheter mapping of scar-related ventricular tachycardia. Circulation 2007 Mar 13; 115(10): 1191-1200.
Reddy VY, Neuzil P, Malchano ZJ, Vijaykumar R, Cury R, Abbara S, Weichet J, McPherson CD, Ruskin JN. View-synchronized robotic image-guided therapy for atrial fibrillation ablation: experimental validation and clinical feasibility. Circulation 2007 May 29; 115(21): 2705-2714.
Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K, Kralovec S, Sediva L, Ruskin JN, Josephson ME. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 2007 Dec; 357(26): 2657-2665.
Dukkipati SR, Mallozzi R, Schmidt EJ, Holmvang G, d'Avila A, Guhde R, Darrow RD, Slavin G, Fung M, Malchano Z, Kampa G, Dando JD, McPherson C, Foo TK, Ruskin JN, Dumoulin CL, Reddy VY. Electroanatomic mapping of the left ventricle in a porcine model of chronic myocardial infarction with magnetic resonance-based catheter tracking. Circulation 2008 Aug 19; 118(8): 853-862.
Reddy VY. Atrial fibrillation: unanswered questions and future directions. Cardiol Clin 2009 Feb; 27(1): 201-216, x-xi.
Reddy VY, Neuzil P, Themistoclakis S, Danik SB, Bonso A, Rossillo A, Raviele A, Schweikert R, Ernst S, Kuck KH, Natale A. Visually-guided balloon catheter ablation of atrial fibrillation: experimental feasibility and first-in-human multicenter clinical outcome. Circulation 2009 Jul 7; 120(1): 12-20.
Ahmed H, Reddy VY. Technical advances in the ablation of atrial fibrillation. Heart Rhythm; In Press.
Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P, P. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 2009 Aug 15; 374(9689): 534-542.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Reddy during 2017 and/or 2018. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting:
- ABIOMED, Inc.
- Biosense Webster
- Boston Scientific Corporation
- CardioFocus
- Cardionomics, Inc.
- Cibiem, Inc.
- Coherex Medical
- EBR, Inc.
- Estech, Inc.
- GDS, Inc.
- Impulse Dynamics
- Keystone Heart Ltd.
- Medtronic, Inc.
- St. Jude Medical, Inc.
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- ACT, Inc.
- Acutus Medical, Inc.
- Apama Medical
- BioSig Technologies, Inc.
- Cibiem, Inc.
- Circa Scientific, LLC
- DC Devices Inc.
- GDS, Inc.
- Javelin, Inc.
- Keystone Heart Ltd.
- Magnetecs Corporation
- Manual Surgical Sciences, LLC
- Middle Peak Medical, Inc.
- NewPace Technology Development Inc.
- Perseus PCI
- VytronUS, Inc.
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose
- BIOTRONIK
- Biosense Webster
- Boston Scientific Corporation
- CardioFocus
- Medtronic, Inc.
- St. Jude Medical, Inc.
Other activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- St. Jude Medical, Inc.
Royalty Payments:
- St. Jude Medical, Inc.
Scientific Advisory Board:
- Boston Scientific Corporation
- CardioInsight Technologies Inc.
- VytronUS, Inc.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.